Europe is grappling with wave two of the Covid-19 virus. But in the US, the numbers show no real sign of turning up – yet. President Trump’s strong showing in…
Read More
Europe’s ‘second wave’ is one more risk factor for the US stock market to navigate. The FOMC can pledge to keep interest rates zero until 2023. It is, indeed, a…
Last week marked the start of a possible correction in technology shares. At one point, it looked as if Friday could morph into a second consecutive day of heavy losses….
The market was due a correction, and while there is a strong case in favour of big tech, the momentum trades are always the biggest casualties. Whether it was the…
Fatalities from Covid-19 remain low in relation to the peak (2,749, April 21st) and low given the jump in infections recorded last month. The Treasury market is focussed on the…
The rise in new infections for Covid-19 in the US is a worry. As noted last week, it is hard to see the stock market making much headway when Covid-19…
Scientists at Moderna have released data that they claimed “back up and inform the pivotal (first) study”. And one dose may be enough to provide protection against Covid-19. ‘Ultra-fast’ Phase…
A strong week for equities saw the S&P 500 climb 3.2% to a close of 2955. The S&P 500 has retraced 62.5% of the losses sustained between February 19th and…
Amazon’s commitment to a “Covid-free network” deserves to be taken seriously. Repeat testing, virus-killing robots (for warehouses, stores etc) and AI to enforce social distancing have given the ecommerce giant…
The reordering of US equities The US stock market did not quite make it pass the April high (2939.5). But Friday’s jump of 3.5% took the S&P 500 up 1.7%…
